H/Cell Energy Corp/ US4041231014 /
05/10/2020 00:00:00 | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.1500USD | - | 6,667 Turnover: - |
-Bid Size: - | -Ask Size: - | 0.2500 | 0.1500 |
GlobeNewswire
30/04
Hydrogen Fuel Cell Microgrid Project: Energy Innovation, Integration and Assurance
GlobeNewswire
06/03
Solidion Technology’s Lithium-Sulfur Batteries on a Launch Pad to Accelerate the Takeoff of the eVTO...
GlobeNewswire
01/03
FuelCell Energy Announces First Quarter of Fiscal 2024 Results Conference Call on March 7, 2024 at 1...
GlobeNewswire
12/12/2023
FuelCell Energy Announces Fourth Quarter and Fiscal Year 2023 Results Conference Call on December 19...
GlobeNewswire
17/03/2022
Grant Cardone's 10X Health System Announces Partnership With DaVinci Medical to Introduce Superhuman...
GlobeNewswire
07/03/2022
FuelCell Energy Announces First Quarter of Fiscal Year 2022 Results Conference Call on March 10, 202...
GlobeNewswire
18/01/2022
Rafael Pharmaceuticals Announces Ongoing Successful Enrollment and Opening of Additional Sites for P...
GlobeNewswire
06/01/2022
Rafael Pharmaceuticals Announces Successful Completion of Dose Escalation with No Dose-Limiting Toxi...
GlobeNewswire
13/12/2021
Rafael Pharmaceuticals Announces Published Data on CPI-613® (Devimistat) From Phase 2 Clinical Trial...
GlobeNewswire
11/11/2021
Rafael Pharmaceuticals Announces First Patient Enrolled in APOLLO 613 Phase 1/2 Clinical Trial of CP...
GlobeNewswire
03/11/2021
European Medicines Agency Grants Orphan Drug Designation to Rafael Pharmaceuticals’ CPI-613® (Devimi...
GlobeNewswire
28/10/2021
Rafael Pharmaceuticals Provides Update on Pivotal Phase 3 Clinical Trial in Patients with Metastatic...
GlobeNewswire
06/10/2021
Leading Edge Materials Announces Proposed Joint Venture Plans for Advanced Anode Materials Business ...
GlobeNewswire
27/09/2021
Rafael Pharmaceuticals Announces APOLLO613 Phase I/II Clinical Trial of CPI-613® (devimistat) in Com...
GlobeNewswire
26/08/2021
President and CEO of Rafael Pharmaceuticals, Sanjeev Luther, to Present at the 11th Annual World Orp...
GlobeNewswire
25/08/2021
Rafael Pharmaceuticals Announces the Successful Completion of Phase 1b Clinical Trial and Initiates ...
GlobeNewswire
12/08/2021
REPEAT -- Alkaline Fuel Cell Power Corp. Provides Technology and Target Market Overview
GlobeNewswire
12/08/2021
Alkaline Fuel Cell Power Corp. Provides Technology and Target Market Overview